DELLY identified 435 inter-chromosomal rearrangements that were private to lymphoblastoid cell line CGH10N. Of these, 53 (12%) were supported by one or more split reads and a consensus sequence in the tumor genome for the rearrangement was reported by DELLY. We found that 13 (25%) of the consensus sequences had a GC composition less than 20%, indicating low sequence complexity (AT repeats). To further investigate, we re-aligned each consensus sequence to the hg19 reference genome using the local alignment algorithm BLAT. In each panel, a point corresponds to a single BLAT alignment. For several sequences, we were not able to identify BLAT records at the two regions reported by DELLY (e.g, sequences 1-5). Among sequences that overlap both regions reported by DELLY, we often found multiple high quality alignments at other locations in the genome (e.g., sequences 7, 13, 14, and 18). Similarly, sequences with a very high BLAT alignment score to both DELLY regions suggests that the two regions have a similar sequence composition (e.g., sequence 9, 23, 43, and 44). With these considerations, only three of the 53 sequences (sequences 6, 15, and 27) have a split read BLAT alignment consistent with the rearrangement reported by DELLY and are less likely to be explained by alignment artifacts. Because all of these regions have five or more paired end alignments reported by DELLY, we check whether a similar number of discordantly read pairs could be identified from the ELAND alignments. We found that only 14 of the 53 regions have improperly paired reads supported by ELAND. Of these, half have fewer than five discordantly paired reads and two have more than 100 discordantly paired reads. Circos plots (left) depict copy number alterations as well as intra-and inter-chromosomal rearrangements. Many ovarian cell lines have amplicons that can be genomically linked. For example, cell line OVSAHO had multiple amplicons that were linked by rearranged read pairs. We visualize the linked amplicons by a graph. Amplicons comprise the nodes and edges indicate amplicons that were linked by 5 or more read pairs. The size of each node is proportional to the number of edges that connect to other amplicons. Triangles denote amplicons spanning potential drivers. Whole genome sequencing analysis identified a YAP1-MAML2 fusion in ovarian cell line ES-2. Related to Figure 5 . The locations of YAP1 (blue rectangle, positive strand) and MAML2 (beige rectangle, negative strand) are indicated as rectangles on the q-arm ideogram of chr11. Rearranged read pairs and split reads indicate an inversion where the 3' end of YAP1 is fused to the 5' end of MAML2 such that MAML2 is now under control of the YAP1 promoter. The full transcripts with shading indicating the spliced regions (between exons 6 and 7 of YAP1 and exons 1 and 2 of MAML2 ), and grey regions indicating the parts of the complete transcript missing in the fused transcript. The amino acid sequence of YAP1 fused to MAML2 at the locations indicated by the dashed lines is the same as the amino acid sequence in the full protein, indicating that the fusion is in-frame. Note, the breakpoint in MAML2 amino acid sequence (aa 172) is the exact same breakpoint previously reported in MECT1-MAML2 and MAML2-MECT1 fusions. Finally, the fused protein with acidic and Q-rich domains of MAML2 (not drawn) remain intact. The fusion involved the promoter and first three exons of IKZF2 and exons 2-27 of ERBB4 (left). Right: Three probes on the Agilent 44k microarray interrogate the first three exons of IKZF2 and two probes interrogate exons 2-27 of ERBB4. The average expression for probes hybridizing to these regions (y-axis) are similarly elevated in cell line ES-2 (black), suggesting that the fusion transcript is over-expressed. For cell lines without IKZF2-ERBB4 fusion (gray), ERBB4 is expressed at lower levels and the relationship between expression of ERBB4 and IKZF2 appears random.
(B) Copy number and rearrangement analyses identified a fusion of SHANK2-CCND1 that involves amplification of CCND1 in cell line ES-2. Expression of CCND1 in tumor ES-2 is high relative to its expression in other cell lines without this fusion (black). (C) In OVCAR-8, the fusion of the promoter of FAM160A1 with the full length FBXW7 gene resulted in decreased expression of FBXW7. This alteration is consistent with the tumor suppressive function of FBXW7 and inactivating mutations observed in other tumor types.
MYO1D
ERBB4
MAML2
Figure S10: Under-expression of genes with homozygous and/or hemizygous deletions. Related to Figure 5 . The probability that a gene was under-expressed was estimated by a two-component hierarchical mixture model implemented in the R package CNPBayes. The horizontal dashed line is the maximum observed expression value for which a gene was underexpressed with posterior probability 0.5 or greater. The strip labels indicate the gene expression probe and, if methylation was detected, the probe from the methylation platform. Triangles indicate methylated CpG sites (β > 0.2). Figure S11: Gene amplifications were often over-expressed. Related to Figure 5 . The probability that a gene was over-expressed was estimated by a two-component hierarchical mixture model implemented in the R package CNPBayes. The horizontal dashed line is the minimum observed expression value for which a gene was over-expressed with posterior probability 0.5 or greater. The strip labels indicate the gene expression probe.
